Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 09688 ZAI LAB-B > Detailed Quotes

09688 ZAI LAB-B

Watchlist
26.750
+0.150+0.56%
Closed 06/30 16:08 CCT
High
27.550
Open
27.300
Turnover
32.21M
Low
26.500
Pre Close
26.600
Volume
1.19M
Market Cap
26.19B
P/E(TTM)
Loss
52wk High
142.000
Shares
979.09M
P/E(Static)
Loss
52wk Low
17.600
Float Cap
26.19B
Bid/Ask %
-37.53%
Historical High
151.200
Shs Float
979.09M
Volume Ratio
0.42
Historical Low
17.600
Dividend TTM
--
Div Yield TTM
--
P/B
2.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.12%
Amplitude
3.95%
Avg Price
27.016
Lot Size
100
Float Cap
26.19B
Bid/Ask %
-37.53%
Historical High
151.200
Shs Float
979.09M
Volume Ratio
0.42
Historical Low
17.600
Dividend TTM
--
P/B
2.56
Dividend LFY
--
Turnover Ratio
0.12%
Amplitude
3.95%
Avg Price
27.016
Lot Size
100
Price Forecast

No Data

News

Comment

Company Overview More
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals dedicated to the discovery or licensing, development and commercialization of proprietary therapies to address a large number of unmet medical needs in the Chinese market, including oncology, autoimmunity and infectious diseases. The company has a range of patent candidates from the discovery phase to the later stages of the clinical program. It includes Niraparib (ZL-2306), ZL-2103, ZL-1101 and so on.
CEO: Ying Du
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top